NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity
Background The development of pathological cardiac hypertrophy involves the coordination of a series of transcription activators and repressors, while their interplay to trigger pathological gene reprogramming remains unclear. NULP1 (nuclear localized protein 1) is a member of the basic helix‐loop‐h...
Main Authors: | Xin Zhang, Fang Lei, Xiao‐Ming Wang, Ke‐Qiong Deng, Yan‐Xiao Ji, Yan Zhang, Hongliang Li, Xiao‐Dong Zhang, Zhibing Lu, Peng Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-08-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.120.016419 |
Similar Items
-
How does NFAT3 regulate the occurrence of cardiac hypertrophy?
by: Wang Hui, et al.
Published: (2023-10-01) -
Herpud1 suppress angiotensin II induced hypertrophy in cardiomyocytes
by: Mei Mikawa, et al.
Published: (2022-07-01) -
Calcineurin /NFAT activation-dependence of leptin synthesis and vascular growth in response to mechanical stretch
by: Nadia Soudani, et al.
Published: (2016-09-01) -
Carboxyl‐Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway
by: Xiaoxiong Liu, et al.
Published: (2018-07-01) -
NFAT signaling dysregulation in cancer: Emerging roles in cancer stem cells
by: Yibin Lin, et al.
Published: (2023-09-01)